Why biotech revenue projections ‘won’t look as sunny’ once Trump tax bill hits Medicaid enrollment
From the article
Insurance coverage losses caused by the Trump administration's tax and spend law could make it harder for biotechs to secure funding and recruit patients for trials, experts have told Fierce.
Continue reading on Fierce BiotechYou might also wanna read
Trump administration's new Medicaid work rules expected to cause significant coverage losses and administrative challenges
The Trump administration issued strict new Medicaid work requirements that experts say could lead to greater-than-expected coverage losses f
Obamacare Enrollment Declines Driven by Subsidy Cuts, Not Removing Fraudulent Enrollees
Radio Free·2d ago
Affordable Healthcare Emerges as a Voter Priority in Purple Nevada
KFF Health News·8d ago

Planned Parenthood restarts Medicaid billing after Trump defunding last year closed clinics, hitting services like breast cancer and STD screenings
FORTUNE·2d ago

STAT+: GOP lawmakers push Trump’s FDA to make sure clinical trials are diverse
STAT·3d ago
Groups Fight to Keep Medical Expenses Tax Deductible
ltcnews.com·7y ago

Comments
Sign in to join the conversation.
No comments yet. Be the first.